Go to deals
Software & Technology

Dye & Durham has completed an IPO onto TSX along with a primary and secondary placing

Dye & Durham Corporation has raised funds through an IPO and a primary and secondary placing.

Dye & Durham is a leading provider of software and technology solutions designed to boost efficiency and increase productivity for legal and business professionals. The Dye & Durham platform connects the largest global network of professionals with public records to support business transactions and regulatory compliance.

Oaklins Cavendish’s sister firm finnCap, based in the UK, acted as the placing agent for Dye & Durham in this transaction.

Talk to the deal team

Peter Gray

Partner
London, United Kingdom
Oaklins Cavendish

Related deals

Niscon Inc. has been acquired by SGPS ShowRig
Broadcasting, Streaming & Entertainment | Events | Software & Technology

Niscon Inc. has been acquired by SGPS ShowRig

Niscon Inc. has been successfully acquired by SGPS ShowRig, a global provider of staging, rigging and automation for live entertainment. The acquisition reinforces SGPS Showrig’s commitment to pushing the boundaries of innovation in the entertainment industry. By adding Niscon’s unique motion-control technology to its portfolio, SGPS Showrig strengthens its ability to deliver cutting-edge, precision-driven solutions.

Learn more
OSL has been acquired by Terma
Software & Technology

OSL has been acquired by Terma

OSL Group Limited, a leader in counter-drone security and safety systems, has been acquired by Terma AS, a Denmark-based global provider of mission-critical solutions for defense, aerospace and security.

Learn more
Banook, backed by Motion Equity, has acquired Fluidda
Healthcare Communications & Technology | Software & Technology

Banook, backed by Motion Equity, has acquired Fluidda

Banook Group has acquired Fluidda NV, marking a strategic expansion into advanced in-silico trials and respiratory disease modeling. Combining Banook’s expertise in cardiac safety and clinical data services with Fluidda’s AI-driven respiratory analytics creates a powerful, integrated platform. This deal strengthens Banook’s position in the contract research organization (CRO) sector, offering pharmaceutical clients broader, technology-enabled solutions to drive drug development and reduce costs.

Learn more